PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

abaloparatide vs albuterol

Side-by-side comparison of abaloparatide and albuterol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
abaloparatide PTHrP Analog
albuterol Short-Acting Beta-2 Agonist
Type
abaloparatide Prescription
albuterol Prescription
Summary
abaloparatide

Tymlos is a medicine to treat osteoporosis. It helps make your bones stronger and less likely to break.

albuterol

Albuterol is a drug that helps you breathe easier. It opens up your airways when they get too narrow.

What It Treats
abaloparatide

Tymlos treats osteoporosis in women after menopause and in men. It is for people who have a high chance of breaking a bone. This includes those who have already had a bone break due to osteoporosis or have other risk factors. It can also be used if other osteoporosis treatments did not work or could not be tolerated.

albuterol

This medicine treats or prevents bronchospasm in adults and kids 4 years and older who have reversible obstructive airway disease. This means it helps when your airways narrow, making it hard to breathe. It can also prevent bronchospasm caused by exercise in adults and kids 4 years and older.

How It Works
abaloparatide

Tymlos is similar to a natural hormone in your body. It helps your body build new bone. This makes your bones stronger and less likely to break.

albuterol

Albuterol is a beta-2 agonist. It works by relaxing the muscles in your airways. This allows more air to flow in and out of your lungs.

Common Side Effects
abaloparatide
  • High calcium in your urine
  • Feeling dizzy
  • Feeling sick to your stomach
  • Headache
  • Feeling your heart beat fast or irregularly
albuterol
  • Throat irritation
  • Viral respiratory infections
  • Upper respiratory inflammation
  • Cough
  • Muscle or bone pain
FAERS Reports
abaloparatide
  • Headache 4,180
  • Feeling sick to your stomach 3,222
  • Feeling dizzy 3,122
  • Feeling tired 2,742
  • Increased heart rate 2,139
albuterol
  • Difficulty breathing 15,966
  • Asthma 9,278
  • Drug not working 8,811
  • Cough 7,340
  • Pneumonia 6,990
Serious Warnings
abaloparatide

Tymlos may increase the risk of bone cancer (osteosarcoma). You should not take this medicine if you have certain conditions that increase this risk. These include Paget's disease, bone cancer, radiation treatment to your bones, or certain hereditary disorders. If you have symptoms of feeling dizzy, palpitations, tachycardia, or nausea, you should sit or lie down.

albuterol

In rare cases, this medicine can make your bronchospasm worse. If this happens, stop using it right away and get medical help. Using too much albuterol can be fatal. If you need more albuterol than usual, your asthma may be getting worse.

Pregnancy
abaloparatide

Tymlos is not for women who could get pregnant. It is not known if Tymlos can harm an unborn baby or pass into breast milk.

albuterol

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if albuterol will harm your unborn baby. Talk to your doctor about the risks and benefits of using albuterol while pregnant or breastfeeding.

How to Read This abaloparatide vs albuterol Comparison

abaloparatide is classified in the PTHrP Analog drug class, while albuterol sits within the Short-Acting Beta-2 Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abaloparatide has 15,405 submissions while albuterol has 48,385. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abaloparatide and albuterol — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.